Urolithiasis 2

[1]  K. Yoshida,et al.  Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. , 1992, Biochemical and biophysical research communications.

[2]  R. Cancedda,et al.  cDNA cloning and gene expression of chicken osteopontin. Expression of osteopontin mRNA in chondrocytes is enhanced by trypsin treatment of cells. , 1991, The Journal of biological chemistry.

[3]  D. Tenen,et al.  Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. , 1989, Biochimica et biophysica acta.

[4]  M. Resnick,et al.  Surface interaction between glycosaminoglycans and calcium oxalate. , 1989, The Journal of urology.

[5]  W. Butler,et al.  The nature and significance of osteopontin. , 1989, Connective tissue research.

[6]  Y. Nakagawa,et al.  Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. , 1987, The Journal of clinical investigation.

[7]  Ryall Rl,et al.  Independent assessment of the growth and aggregation of calcium oxalate crystals using the Coulter counter. , 1981 .

[8]  M. Takaha,et al.  Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation. , 1981, Investigative urology.

[9]  W. Robertson,et al.  Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro? , 1980, Clinica chimica acta; international journal of clinical chemistry.

[10]  R. Bowyer,et al.  Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggregation. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[11]  J. Sallis,et al.  On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones. , 1979, Investigative urology.

[12]  J. Lian,et al.  The presence of protein-bound gamma-carboxyglutamic acid in calcium-containing renal calculi. , 1977, The Journal of clinical investigation.

[13]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[14]  M. Peacock,et al.  Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[15]  R. Hata,et al.  A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis. , 1972, Analytical biochemistry.

[16]  E. Lyon,et al.  Mechanisms of genesis and growth of calculi. , 1968, The American journal of medicine.

[17]  W. Boyce.  Organic matrix of human urinary concretions. , 1968, The American journal of medicine.

[18]  T BITTER,et al.  A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.

[19]  L. Pyrah,et al.  The composition, structure, and mechanisms of the formation of urinary calculi. , 1962, British journal of urology.

[20]  B. Finlayson,et al.  Stone matrix and mucoprotein from urine. , 1961, The Journal of urology.